Dendritic cell-based immunotherapy

被引：628
|
作者：
Sabado, Rachel L. [1 ]
Balan, Sreekumar [1 ]
Bhardwaj, Nina [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
来源：
CELL RESEARCH | 2017年 / 27卷 / 01期
关键词：
dendritic cell; immunotherapy; CERVICAL-CANCER PATIENTS; REGULATORY T-CELLS; INTEGRATED IMMUNE-RESPONSE; LONG PEPTIDE VACCINE; MELANOMA PATIENTS; IN-VIVO; SIPULEUCEL-T; LYMPH-NODES; LISTERIA-MONOCYTOGENES; ANTITUMOR IMMUNITY;
D O I：
10.1038/cr.2016.157
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for harnessing the potential of a patient's own immune system to eliminate tumor cells in metastatic hormone-refractory cancer. Overall, although many DC vaccines have been tested in the clinic and proven to be immunogenic, and in some cases associated with clinical outcome, there remains no consensus on how to manufacture DC vaccines. In this review we will discuss what has been learned thus far about human DC biology from clinical studies, and how current approaches to apply DC vaccines in the clinic could be improved to enhance anti-tumor immunity.
引用
收藏
页码：74 / 95
页数：22
相关论文
共 50 条
  • [41] Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
    Van Acker, Heleen H.
    Versteven, Maarten
    Lichtenegger, Felix S.
    Roex, Gils
    Campillo-Davo, Diana
    Lion, Eva
    Subklewe, Marion
    Van Tendeloo, Viggo F.
    Berneman, Zwi N.
    Anguille, Sebastien
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [42] Principles of dendritic cell-based immunotherapy in myeloid leukemia
    Westers, Theresia M.
    Houtenbos, Ilse
    van de Loosdrecht, Arjan A.
    Ossenkoppele, Gert J.
    IMMUNOBIOLOGY, 2006, 211 (6-8) : 663 - 676
  • [43] Potential of dendritic cell-based immunotherapy of multiple sclerosis
    Link, H
    Xiao, BG
    Huang, YM
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S8 - S9
  • [44] Dendritic cell-based immunotherapy for patients with malignant glioma
    Chernykh, E.
    Stupak, V.
    Leplina, O.
    Shevela, E.
    Pendurin, I.
    Nikonov, S.
    Ostanin, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S161 - S161
  • [45] Immunotherapy of cancer with dendritic cell-based tumor vaccines
    Gilboa, E
    Nair, SK
    Boczkowski, D
    Mitchel, D
    Faiola, B
    CANCER GENE THERAPY, 1997, 4 (05) : 314 - 314
  • [46] Dendritic cell-based immunotherapy for malignant pleural mesothelioma
    Aerts, Joachim G.
    Veltman, Joris
    Lambers, Margaretha
    Lambrecht, Bart N.
    Hoogsteden, Henk C.
    Hegmans, Joost J.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S750 - S750
  • [47] Optimizing dendritic cell-based immunotherapy in multiple myeloma
    Yi, Q
    Desikan, R
    Barlogie, B
    Munshi, N
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) : 297 - 305
  • [48] Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
    Matsuo, Kazuhiko
    Yoshie, Osamu
    Kitahata, Kosuke
    Kamei, Momo
    Hara, Yuta
    Nakayama, Takashi
    CANCERS, 2021, 13 (10)
  • [49] Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors
    Kang, Byeong Hoon
    Lee, Heung Kyu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [50] Novel perspectives on dendritic cell-based immunotherapy of cancer
    Bonaccorsi, Irene
    Pezzino, Gaetana
    Morandi, Barbara
    Ferlazzo, Guido
    IMMUNOLOGY LETTERS, 2013, 155 (1-2) : 6 - 10
12345